Infarct volume-based subgroup selection in acute ischemic stroke trials.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 25765724.
- Also identified by DOI 10.1161/STROKEAHA.114.008115.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We investigated whether hyperintensities with a diameter of at least 3, 3.5, and 4 cm and visible on at least 3 slices on diffusion-weighted imaging enables patient selection with an infarct volume of ≥15 mL. Consecutive acute stroke patients were screened for the AXIS2 trial and examined according to a standardized magnetic resonance imaging protocol in 65 sites. Diffusion-weighted lesion diameters were measured and compared with volumetric assessments. Out of 238 patients, 86.2% (N=206) had infarct diameter of at least 3 cm. Volumetric assessments showed infarct volume of ≥15 mL in 157 patients. A cut-off value of 3 cm led to 96.8% sensitivity and 33.3% specificity for predicting lesion volume of ≥15 mL. Analogously, a 3.5 cm cut-off led to 96.8% sensitivity and 50.6% specificity and a 4 cm cut-off led to 91.7% sensitivity and 61.7% specificity. Lesion diameter measures may enable multicentric patient recruitment with a prespecified minimal infarct volume. URL: http://www.clinicaltrials.gov. Unique identifier: NCT00927836.
Medical subject headings
- Brain Ischemia
- Cerebral Infarction
- Stroke